NEW YORK, Feb. 12, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Navient Corporation (“Navient” or the “Company”) (Nasdaq:NAVI) in the United States District Court for the District of Delaware on behalf of a class consisting of all persons or entities who purchased Navient securities between May 9, 2014 through February 5, 2016, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that, throughout the Class Period, Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Navient’s loan servicing practices were not in compliance with applicable federal regulations; (2) Navient’s non-compliance with federal regulations could subject Navient and its subsidiaries to restitution, civil monetary penalties, and corrective actions; (3) as a result, Defendants’ statements about Navient’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].
Please visit our website at http://www.gme-law.com for more information about the firm.


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



